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Abstract
Probabilistic modeling is fundamental to the statistical analysis of com-
plex data. In addition to forming a coherent description of the data-generating
process, probabilistic models enable parameter inference about given data
sets. This procedure is well-developed in the Bayesian perspective, in
which one infers probability distributions describing to what extent var-
ious possible parameters agree with the data. In this paper we motivate
and review probabilistic modeling for adaptive immune receptor reper-
toire data then describe progress and prospects for future work, from germ-
line haplotyping to adaptive immune system deployment across tissues.
The relevant quantities in immune sequence analysis include not only con-
tinuous parameters such as gene use frequency, but also discrete objects
such as B cell clusters and lineages. Throughout this review, we unravel
the many opportunities for probabilistic modeling in adaptive immune re-
ceptor analysis, including settings for which the Bayesian approach holds
substantial promise (especially if one is optimistic about new computa-
tional methods). From our perspective the greatest prospects for progress
in probabilistic modeling for repertoires concern ancestral sequence esti-
mation for B cell receptor lineages, including uncertainty from germline
genotype, rearrangement, and lineage development.
Introduction
How to read this paper
• If you are an immunologist and want to learn more about probabilistic
modeling, start here.
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• If you love probabilistic modeling and are curious about immune reper-
toires, you may want to start by getting background in immunology in
general (1) and immune repertoires in particular (2, 3), then reading the
Models section.
• If you already know both topics and get bored easily, skip to your favorite
parts of repertoire analysis.
Why bother with probabilistic models?
Before entering on our quest for model-based analysis of repertoires, one might
ask “why bother?”
The first answer is simple: repertoires are generated by a probabilistic pro-
cess of random recombination, unknown pathogen exposures, and stochastic
clonal expansion. Thus, when analyzing repertoires it behooves us to reason
under uncertainty. The last century of statistical development offers a refined
set of tools to make statements about such systems and assess our confidence
in them.
Second, repertoire data shows us that complex models are justified. For
example, not all germline genes are used with equal frequency in repertoire
generation. The frequency of these germline genes is interesting to measure,
but also informative of which genes were used in specific recombination events
that gave rise to observed sequences. Furthermore, the various genes all have
characteristic distributions of trimming lengths, shown to be consistent be-
tween individuals (4–6); incorporating this further improves annotation and
clustering inference. Such observations can also suggest mechanistic hypothe-
ses that can then be tested with experiments.
Third, the probabilistic approach offers a principled means of accounting
for hidden latent variables that form an essential part of the model, but are
not themselves of direct interest to the researcher. For example, we may not
care about the exact rearrangement event that led to a given B cell receptor,
but this is still an important latent variable for clustering analysis: indeed, one
should only cluster receptors that came from identical rearrangement events.
Thus one can sum over the possible rearrangement events that led to this clonal
family, leading to a natural means of evaluating a clustering likelihood (7) that
averages out uncertainty in the rearrangement process.
Fourth, probabilistic models have well-developed notions of model hierar-
chy, in which inferences at each level inform and are informed by inferences at
other levels. This is essential to leverage the hierarchical structure present in
immune receptor data (Fig. 1). For example, performing inference using many
sequences at once (e.g. germline inference) can greatly improve per-sequence
inferences, performing lots of per-individual germline inferences can tell us
about the germline biases of a population, and so on up the hierarchy.
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Figure 1: Immune repertoires are hierarchically structured, here illustrated by
the hierarchy for B cell receptor sequences. We benefit by considering the
whole hierarchy that contributes to our observable sequences rather than one
sequence at a time. For example, by considering all the reads at once one can
infer a personal germline set, which then informs the per-read annotation. By
learning lots of personal germline sets one can infer population-level germline
trends.
Model-based probabilistic analysis
We begin by introducing model-based probabilistic analysis, and providing a
very casual introduction to maximum-likelihood and Bayesian analysis as they
apply to immune repertoires.
Consider a very simple model of the distribution of heights in a human
population: a normal (a.k.a. Gaussian) distribution. Say we have observed the
height of all 127 million humans in Japan, rounded to the nearest centimeter,
and we have plotted it as a histogram. As a first approximation, one can think
of fitting a probabilistic model as grabbing a normal distribution and flexing
it with our hands until it looks as much as possible like that histogram. If its
estimates are too small, for example, we can scoot it right, and if it is too narrow
we can bend it so it is broader.
This process can be formalized in terms of the principle of maximum like-
lihood, in which we find the parameter values that are most likely to have
generated the observed data. The likelihood function of the model parame-
ters can again be thought of as “the probability of obtaining the observed data
under the given model with those parameters.” Although not quite a rigor-
ous definition for all settings, this definition is rigorous for discrete data such
as heights rounded to the nearest centimeter, or DNA sequences. For a nor-
mal distribution model, which is parameterized by mean µ and variance σ2,
we can directly calculate this likelihood function. This likelihood is a prod-
uct of terms, one for each human, equal to the Gaussian probability density
(2piσ2)−1/2 exp[−(x − µ)2/2σ2], where x is the height of that human. It turns
3
Olson & Matsen Bayesian adaptive immune receptor analysis
V genes D genes J genes
Affinity
maturation
Somatic hypermutation
VDJ
rearrangement
including
erosion and
non-templated
insertion
AntigenNaive B cell
Experienced B cell
μ 2σ
Normal distribu�on B cell receptor forma�on
two parameters thousands of parameters
de
ns
ity
Figure 2: Human height and immune receptor formation can both be modeled
using probabilistic methods. Right panel modified (with permission) from (4).
out that the usual formulas for the mean (i.e. the sample average) and the
(biased) sample variance (the average squared deviation from this mean) are
exactly the maximum likelihood values of these parameters: those values that
maximize the likelihood function!
One can also approximate the likelihood function using repeated simula-
tion for a single set of parameters, as we illustrate using the following thought
experiment. In the heights example, we can estimate the likelihood as follows:
generate many samples of size 127 million from a normal distribution rounded
to the nearest integer, and calculate the fraction of times we get exactly the ob-
served set of heights. Although this will be an extraordinarily small number, it
will be larger for parameter values that fit well (the normal distribution fits the
histogram of measurements closely) than for ones where it does not, and thus
is a means of doing parameter fitting. [Note that these two perspectives on
optimizing our model, that of picking model values such that simulation is as
close as possible to observation, and that of maximizing a likelihood function,
are actually identical if we define “as close as possible” in terms of Kullback-
Liebler (8) divergence.]
The inferential setup is the same for immune repertoire analysis, except that
the models and data are more complex (Fig. 2). Rather than having a model that
generates human heights, models for immune repertoire analysis generate im-
mune repertoires as collections of DNA sequences. In a similar way, fitting
such models is a process of wiggling the parameters until the model generates
repertoires that are as similar as possible to the observed repertoires. In certain
cases we can efficiently compute a likelihood function such that optimizing
this function does the wiggling more formally, using either an exact formula
or approximate numerical routines. However, this is not the case for all mod-
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els, and indeed much of the subject of the second half of this paper describes
models that attempt to make a balance between computability and realism.
For repertoires, we can again imagine maximum likelihood fitting happen-
ing via simulation: we have a model from which we can simulate repertoire
sequences, and we can approximate the likelihood for a collection of parame-
ters for a given data set based on the fraction of times it generates the observed
data exactly. In principle, we can fit the model by iteratively wiggling parame-
ters and re-simulating, preferring those wiggles that more frequently generate
the same data as what was observed. Of course, for real data sets such fit-
ting is sheer lunacy: a repertoire simulation will never once exactly match an
observed repertoire sample containing a million unique sequences even if we
were to run it for our whole lifetimes! Nevertheless, this is a helpful thought
experiment that underlines the importance of likelihood functions, which can
be thought of as a “short cut” avoiding such simulation. We will continue this
thought experiment below.
We can continue the height metaphor to explain Bayesian analysis. Bayes-
ian analysis again concerns model parameters θ. In the heights example, θ is a
pair consisting of the mean µ and the variance σ2. The goal of Bayesian analy-
sis is to not just find the best parameters θ, but to get an ensemble of possible
values of the parameters along with an idea of how well each describes the
data x. This is formalized in the notion of a posterior distribution, which is a
probability distribution on the collection of parameters describing how likely
the various parameters are to be correct given the data. Having a full distribu-
tion over parameters rather than just point estimates allows for a more detailed
characterization of the uncertainty in our inferences. For example, we can sum-
marize this posterior distribution in terms of credible intervals, which are the
Bayesian analog of confidence intervals. To obtain such a posterior distribution
for our height example, we begin by specifying a prior distribution on the pa-
rameters. This prior is our a priori idea of what the heights might be before we
sample any data. We then incorporate the data to get a posterior distribution.
Formally, this comes from the deceptively simple statement of Bayes’ theorem
p(θ | x) ∝ p(x | θ) p(θ)
which states that the posterior distribution p(θ | x) of model parameters θ given
data x is proportional to the likelihood p(x | θ) times the prior p(θ). We can
think of this as re-weighting our prior assumptions based on how well they
explain the data.
This sounds simple enough, but in fact thousands of careers of computa-
tional Bayesians have been dedicated to the challenge posed by Bayes’ theorem
being expressed in terms of proportionality rather than equality. Indeed, even
if we can say how much one parameter set is better than another via Bayes’
theorem, we have to evaluate many different parameters to obtain a value for
the posterior, which makes a statement about how good a given parameter set
is compared to all possible parameters. The situation is analogous to that of
climbers in a mountain range tasked with estimating their height relative to
5
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the average height of the range: it is easy to see that one location is higher
than the other, but evaluating the average height requires traversing the entire
range and taking careful measurements. This is an informal way of saying that
the integral of the posterior distribution is typically intractable.
When the posterior integral is in fact tractable, as can be the case for very
simple models, we can obtain the posterior distribution directly as a formula.
In our height example, if we take a normal prior distribution for the mean with
a fixed variance, we can directly obtain a formula for the posterior distribu-
tion (which turns out to also be normal). However, such directly-computable
models with so-called “conjugate priors” are few and far-between, and none
of them involve immune receptor DNA sequences.
For more complex models we do not attempt to compute the posterior dis-
tribution directly, but rather we sample from it. In this way we obtain a “his-
togram” that approximates the full posterior distribution: in our heights ex-
ample, we would get a collection of (µ, σ2) samples from the joint distribution
on these parameters. It is common to summarize these samples in terms of
their single-variable posterior estimates, which in our example would be one
histogram for the mean of the height distribution and another for the variance.
Although sampling from posterior distributions is a challenging problem,
decades of research has developed sophisticated methods, as well as proba-
bilistic programming languages that are dedicated to the task (9–11). We will
briefly summarize one method (MCMC) below, but first present a completely
rigorous but utterly impractical means of sampling from a posterior distribu-
tion via simulation. In the above thought experiment, we were approximating
the value of the likelihood for a single set of parameters, and here we have an
even more ambitious goal: to approximate the posterior across parameter val-
ues. Repeat the following process to obtain a posterior sample on parameters
given some data:
• draw values of the parameters from the prior
• simulate data using those parameters
• does this simulated data match the observed data exactly?
• if so, add these parameters to our posterior sample, and if not discard
them
• return to the first step until the desired number of samples is obtained
In the height example, each such cycle involves drawing 127 million samples
from a normal distribution and checking if they are the same as the observed
data. The result is a sample from the posterior distribution on µ and σ2. In an
immune repertoire example, we could do the same by simulating sequences,
which is even less practical than the completely impractical idea of applying
this to the height example. Luckily, there are other means of sampling posterior
distributions.
The most common method for sampling from a posterior distribution is
Markov chain Monte Carlo (MCMC). MCMC is a random procedure that moves
around parameter space such that the frequency with which the procedure vis-
its a given parameter is proportional to its posterior probability. The most pop-
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ular type of such inference in phylogenetics is random-walk MCMC (12), in
which parameter values (such as a tree topology and its branch lengths) are
perturbed randomly; these perturbed values are always accepted if they are
“better” and accepted with some probability if they are “worse.” Being able
to accept “worse” parameter modifications is important so that the algorithm
explores the entire space rather than getting stuck at the peak of a distribu-
tion. The notions of “better” and “worse” are determined by the Metropolis-
Hastings ratio, which depends on having a likelihood function that can be eval-
uated efficiently. This sort of sampling is implemented in packages such as
BEAST (13) and MrBayes (14), but due to computational complexity is typi-
cally limited to hundreds of sequences in a single tree.
Before exploring computational challenges, we describe marginalization
and discuss priors. Marginalization is the practice of “integrating out” nui-
sance parameters, which are parameters that are important for the model but
may not be of interest for the researcher. Imagine we were interested in what
D gene was used for a given B cell receptor sequence, and want to take a
probabilistic approach because such assignment is naturally uncertain. In a
likelihood-based approach, one can only evaluate the suitability of a D gene
assignment when we also have specified the amount of trimming encountered
by this D gene, even if that parameter is not actually of interest to us. Therefore
we sum over the possible amounts of D gene trimming. In general this is called
integration because summation is a special case of integration.
Prior distributions require careful consideration. All distributions, includ-
ing prior distributions, have parameters that must be chosen. The parame-
ters of prior distributions are called “hyperparameters.” Where do those come
from? One option is to use a hierarchical Bayesian analysis in which we con-
sider prior parameters as random variables themselves, also requiring prior
distributions. The phylodynamics community have developed sophisticated
methods to infer mechanisms of viral spread using such a hierarchical ap-
proach (15). However, at some point this recursion must end and one must
either fix values arbitrarily or attempt to estimate them from the data. The
process of estimating fixed hyperparameters is known as empirical Bayes (16).
An informally-described hierarchy of inferential difficulty
Here we describe a difficulty hierarchy for maximum likelihood and Bayesian
inference based on how difficult the model is to compute.
1. Conjugate priors available for model: In this case, the posterior is avail-
able as an exact formula. Hence, no sampling is required, and the pos-
terior is extremely efficient to evaluate. Unfortunately, this is never the
case for repertoires.
2. Efficiently computable likelihood function available: Here, maximum
likelihood estimation is tractable, and Bayesian methods can be used
via Markov chain Monte Carlo (MCMC). Phylogenetic trees under mod-
els where each site evolves independently fall into this category, as the
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Felsenstein algorithm (17) provides a means for efficient likelihood eval-
uation. Nevertheless, tree inference is still challenging, and provably
hard (in the technical sense) given difficult data (18) because of the super-
exponential number of trees that must be tried in order to be sure of find-
ing the best one.
Repertoire analysis methods such as hidden Markov models (HMMs, de-
scribed in more detail below) for rearrangement inference also fall into
this category. In this case there is also latent state (that is, the transi-
tion points between germline sequences and the N/P junction between
germline-encoded regions); this latent state can be efficiently marginal-
ized by the Forward-Backward algorithm (4, 19). Bayesian estimation
for such parameters is also possible (20) though has not been applied
to repertoires.
3. Efficiently computed likelihood function available if we condition on
some additional latent state Some models do not have an efficiently-
computable likelihood function in general, though a likelihood can be
computed if we expand the parameters of interest to include some addi-
tional information. For example, the ideal phylogenetic reconstruction
method for repertoire data would take the context-sensitive nature of
somatic hypermutation into account (21). We can efficiently compute a
likelihood function using a context-sensitive model such as S5F (22) if
we specify the order of and time between mutations. However, these
additional parameters are not typically of interest and thus need to be
marginalized out using Markov chain methods (23). For certain classes
of such models, only the order of mutations (versus their exact timing)
matters (24).
4. No likelihood function available When no likelihood function is avail-
able one must resort to simulation-based methods such as approximate
Bayesian computation (ABC) (25). In this method, one obtains approxi-
mate posterior distributions by reducing the data to relevant summaries
and seeing which models produce data that match these summaries well.
Our above thought experiment required an exact match of simulated and
experimentally-derived data in order for a set of parameters to be ac-
cepted. In ABC, one accepts parameters with a probability determined by
how closely pre-specified summary statistics of the simulated data agree
with those of the experimental datasets. This has been applied with suc-
cess in population genetics problems with a modest number of param-
eters. However, as the model complexity grows, even simulation-based
methods suffer the “curse of dimensionality” and will eventually become
intractable.
Any sufficiently detailed model of repertoire generation will land here.
For example, it’s not possible to calculate likelihoods for complex models
based on agent-based simulation (26), although one could sample them
using ABC. In fact, an informal version of ABC is currently used in B cell
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receptor sequence analysis, in which one adjusts simulation parameters
until they generate data that looks close to experimental data according
to a battery of summary statistics (27–29).
We see that there is often a balance between realism and computability; al-
though there is no inherent reason why this must be so, it is often the case. For
example, computation is eased by assuming variables in a model are indepen-
dent, even if that’s not exactly true. In the above hierarchy, this is illustrated
by easy-to-compute site-independent phylogenetic models on one hand versus
hard-to-compute context-dependent models on the other.
Models
Here we describe existing and potential probabilistic models for immune re-
ceptor development. Although in principle any probabilistic model can be
used for inference (via the “thought experiment” inference procedure described
above), we find it useful to distinguish between inferential models and models
for simulation. For the purposes of this paper, inferential models are those that
are meant to be fit to data to learn something about the underlying system.
We will be interested in inferential models that are tractable to use for infer-
ence if one is “optimistic” (marked with ☼): at least, one should be able to do
inference on each individual component using existing machinery.
Models for simulation serve a separate and essential purpose. Such models
can be more complex and need not have an efficiently-computable likelihood
to be useful. Agent-based models, such as models of a germinal center (26) fall
into this category. Models can make predictions, such as the groundbreaking
1993 prediction of cyclic re-entry (30) that was dramatically validated over a
decade later (31, 32). Also, if we want to validate inferential algorithms, we
need accurate generative models. For these reasons we are going to sketch
“lunatic” model components (marked with $) as well, for which we only
require the ability to simulate in forward time.
We will investigate this framework while following receptor development
from the germline gene repertoire to clonal expansion. For every component
of the process, we will follow an identical pattern in this order: biological back-
ground, then previous work on inference, then sections on “optimist” ☼ and
“lunatic” $models. The biological background will of course be a miniscule
fraction of what is known, as we can only include parts that are relevant for
the modeling goals here.
Before we begin this voyage, we note that traditionally biologists and statis-
ticians have slightly different but not incompatible notions of what is meant by
“model.” A biologist’s model is typically a conceptual model describing the
mechanistic process by which something happens. For example, transcription
factor X binds cofactor Y which allows it to initiate transcription of gene Z.
Such a model may not have any parameters and thus cannot “generate” data,
although it can typically be used to devise an experiment to test the hypotheses
9
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Figure 3: Statisticians and biologists have typically approached adaptive im-
mune receptor research in two parallel tracks. Statisticians (upper path) treat
data as given and perform model criticism based on numerical estimates of
how well models fit the data. Biologists (lower path) formulate their mod-
els mechanistically and generate data in targeted experiments to directly test
their model. An integrated approach (dashed arrows) has biologists using pa-
rameter estimates to formulate mechanistic models, and statisticians using the
results of targeted experiments to formulate statistical models. Ideally, the dis-
tinction between these two classes of models would evaporate, although mech-
anistic models are not always readily fit using statistical means.
of the model.
A statistician’s model, on the other hand, need not have any mechanistic
underpinning, although it necessarily contains parameters and can be used to
generate data.
These two perspectives lead to different means of iterative model improve-
ment (Fig. 3). Biologists scrutinize their models for components that can be
separated out and perturbed individually to form a test of the model. This re-
ductionist approach has taught us most of what we know about biology today.
Statisticians, on the other hand, are generally interested in evaluating models
via model fit. That is, if we generate data from our model, does it resemble our
observed data, and are new, unseen data values described well by the model?
If not, how can we add model components that will result in a better-fitting
model? This iterative process of model improvement has been called “Box’s
loop.” (33)
Nonetheless, these viewpoints are quite compatible, and indeed we may
need to combine them to meet the next set of challenges in adaptive immune
receptor research. For the statistician, incorporating mechanism into statistical
models means that inferred parameters have direct interpretation, and such
models typically have fewer parameters. For the biologist, formalizing a bio-
logical model statistically means that models with hidden parameters can be
directly compared in a rigorous way.
With all this introduction out of the way, now we begin considering proba-
bilistic models for adaptive immune repertoires!
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Germline genotype
Although repertoire modeling often starts with V(D)J rearrangement (34), the
rearrangement process is in turn determined by the genotype of each individ-
ual, in particular the collection of germline V, D, and J genes in the loci form-
ing the various receptors. A complete survey (35, 36) is out of the scope of
the paper, but suffice it to say that although complete haplotypes at germline
loci have been sequenced (37–40), the genetic diversity of these loci is high
and many new alleles continue to be discovered, especially in non-Caucasian
populations (41–44). Thus, the germline genotype forms an important part of
the hidden state for repertoire generation (45) with real medical consequences
(41, 46).
This motivates inference of germline genotypes directly from repertoire se-
quence data. Early work performed such inference by carefully considering
several sets of high-throughput sequencing data (5, 47, 48). Kidd et al. used
a maximum likelihood model assuming uniform gene use to infer alleles, and
were able to phase these onto haplotypes for individuals who are heterozygous
at IGHJ6 (48). Later work used naive sequences and an assumption of no gene
duplication to iteratively obtain haplotypes via probabilistic gene assignment
for three individuals (5). More recent work has delivered automated tools for
germline set inference: TIgGER (43), IgDiscover (49), and partis (50). TIgGER
introduced a “mutation accumulation” plot relating mutations at a given site
to the overall level of mutation in sequences. This plot should have a smooth
shape in the absence of new alleles, but a “bend” in the presence of an unan-
notated allele; partis works by explicitly searching for this bend. IgDiscover
applies hierarchical clustering to naive-sorted data to obtain germline sets in
species for which little or no germline information is known.☼ There is a substantial need for probabilistic germline repertoire inference
methods. For example, this would be very useful if we want to estimate the
unmutated ancestor of B cell clonal families while quantifying uncertainty.
Germline gene inference is inferred from a whole repertoire at a time; this
fact alone poses some challenges to a probabilistic method. For example, if
we wish to compare two germline gene sets, naively one would need to per-
form a complete re-alignment of all sequences to obtain a likelihood. Because
such a likelihood is available, it can be formally classified as “efficient” (sec-
ond category in the above hierarchy) although such repeated re-alignment is
not practical for large data sets. Some cleverness would be helpful here, such as
only re-annotating sequences that could be affected by changing the germline
set. Another alternative would be to infer a too-large pool of possible candi-
date germline genes, perform probabilistic alignment using all of these germ-
line sequences, and use the associated probabilities without running complete
re-alignment in a second step to cut down the pool.
Haplotype inference has been shown to be a useful tool for cutting down
germline sets from such a candidate pool (5, 51). This works by assuming lim-
ited or no gene duplication of individual genes in a germline set, and then
using joint gene usage under VDJ recombination to infer which alleles lie on
11
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which haplotype. One can then review the gene assignments and reject sus-
picious inferences, since having many alleles of a given gene inferred to lie on
a single haplotype casts doubt on their authenticity. This method does have
some caveats. It requires heterozygosity at J (or D) genes, and that the V gene
in question is expressed at reasonable levels on both chromosomes. Also, the
immunoglobulin germline locus is dynamic with many gene duplication and
conversion events, so we cannot exclude the possibility of many alleles of a
gene being present on a haplotype.
Despite these caveats, in order to have the best germline gene inference
it may be useful to extend inference to the full pair of haplotypes, called a
“diplotype.” In order to do so we will need to formalize generative models
on diplotypes, which could act as a prior for inference. Ideally, such a gener-
ative model would come from observing many diplotypes. As noted above,
such direct haplotype sequencing is rare, but this situation may change using
improved assembly techniques applied to long-read sequencing data. Alter-
natively, one could build up such a model by taking a large ensemble of data
sets and iteratively estimating haplotypes and prior parameters (determining,
e.g. the prior distribution of the number of alleles per gene) using empirical
Bayes. A parameterized prior could be developed based on racial background,
in which people with genetic ancestry from various places would have a differ-
ent distribution of germline genes. The biological importance of gaining broad
diplotype information has been carefully laid out in a recent review (45).
In principle one could directly use probabilistic methods to infer a pool
of possible germline sequences, although here the problem of requiring re-
annotation becomes much more acute because of the many hypotheses that
must be tried. The TIgGER mutation accumulation plot gives the values of a
complex conditional probability, and at least for the near term it makes sense to
continue using this summary. Its analysis could be improved by more flexible
models of how mutations accumulate on sequences— current efforts implicitly
assume that each site accumulates mutations linearly as a function of the total
number of mutations on that sequence.$ Germline genotypes differ between individuals in a population and be-
tween populations and species because of long-time-scale evolutionary pro-
cesses; it is already tempting to work to better understand these processes of
mutation and selection. In terms of mutation, one may wish to connect germ-
line gene change with mechanistic models of gene duplication and loss (52).
Analysis of large populations (53), especially using parent-offspring data (54),
will be important to develop such models. It is also tempting to infer selection
on germline gene sets to maintain a diverse pool of starting material for VDJ
rearrangement, as well as to make it easier to mount an antibody-mediated
response against locally-important pathogens. Much more data, in particular
data spread across many more populations, will be required to perform such
inference.
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Rearrangement
By “rearrangement” we mean joint gene choice, trimming, and insertions in the
process of V(D)J recombination (55) without any selective steps for tolerance or
binding. Biologically, this is determined at least in part by gene location, pres-
ence of recombination signal sequences (56), chromatin accessibility of these
sequences (55), and long-range loop structure (57). There are surely additional
complex genetic determinants of the rearrangement process, and how those
contribute to repertoire formation will be a continued topic of research.
This complex machinery leads to a complex probabilistic process that de-
termines rearrangement (36). Prior work has found interaction between N nu-
cleotide addition and recombination (58) as well as dependence between D and
J gene use in BCRs (59). There is also clear evidence of interaction between gene
use and trimming length (4,60). The rearrangement processes change with age,
a phenomenon recently quantified in mouse (61). In addition to the usual rear-
rangement process, oddities such as VH replacement (62–64) and inverted and
multiple D genes do occur, although recent analyses indicate that these are rare
in the overall repertoire (65, 66).
This process is greatly deserving of complex models, as all variables de-
termining the rearrangement process are both interesting and decidedly non-
uniform. Indeed, many probabilistic models have been formulated, with the
hidden Markov model (HMM) framework being particularly popular (6, 60,
65, 67, 68). Various implementations of the HMM differ in the parameteriza-
tion of gene choice and trimming distributions, with the trend being towards
parameter-rich categorical distributions for trimming. Such rich distributions
are justified by the observation that although trimming distributions are dif-
ferent between genes, strong concordance between individuals shows that the
models are not simply fitting noise (6,60,69). Recent work has extended this to
a more general modeling framework expressible in terms of an arbitrary Bayes-
ian network (69). For the insertion sequences, applying an HMM has shown
dependence of the next base on the previous one (60).☼ Despite substantial progress, there is still work to be done describing the
rearrangement process using probabilistic models. The distribution of inserted
sequences invites further exploration: are more complex models warranted?
Although current models are inferred per-data-set, it would be helpful to have
models that can concern multiple related data sets and parameterize differ-
ences between them using covariates such as age (61). Such models may also
be useful to infer differences in the rearrangement process by genetic back-
ground (41, 46, 70). An obvious if formidable next step is to extend current
probabilistic models to include complex rearrangements such as replacement
and multiple D genes.$ It will be more challenging to relate these descriptive statistical models to
mechanism. As described above, gene choice is determined by recombination
signal sequence strength and accessibility. Sequence features must also govern
the amount of trimming, and early work found sequence motifs that change the
distribution of trimming amounts (71,72). This work has not been extended in
13
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our current era of abundant high-throughput sequencing data sets. However,
our biological knowledge has also expanded: we now know gene choice is
determined by processes including megabase-scale loops and chromatin state,
although the roles of various processes such as hairpin opening and nucleotide
deletion to germline gene trimming are still something of a mystery. Since
these processes are so complex, any proposed model will have to judiciously
choose a balance between realism and tractability. Also, such a project will
require diverse expertise in statistical modeling and biological mechanism.
Initial selective filters
Positive and negative selection determines which B and T cells are able to cir-
culate. Positive selection ensures that T cells are able to bind major histocom-
patibility complex (MHC) molecules of the host. Negative selection happens
to avoid self-reactivity and maintain an appropriate level of interaction with
MHC. In B cells the initial selective processes ensure that a functional antibody
is produced with limited self-reactivity.
For B cells, previous work has found selection against long and/or hy-
drophobic HCDR3 loops (73) as well as selection on germline gene use (74)
and D gene frame (75). Others have inferred “selection factors” for various as-
pects of the TCR (76) and BCR (5) in the initial selective process. These factors
are multiplicative terms that describe the probability of seeing a sequence with
a specific characteristic in the post- vs pre-selection repertoire. For example,
a selection factor for a specific amino acid at a specific location quantifies the
level to which this amino acid is selected for or against.☼ There are still many possible ways to extend analysis of “bulk” character-
istics of sequence-level selection. Current methods analyze the role of a single
feature at a time, such as CDR3 length or particular selection factors, and it
would be interesting to look for selection on sets of factors. Paired heavy/light
and alpha/beta chain data is also an interesting source for such joint selection
analysis (77–79). It will also be important to take MHC type into account when
performing such analysis and look for MHC-mediated effects, although the
largest analysis so far found relatively few TCRs that were negatively associ-
ated with MHC (80).$ It will be very difficult to make the leap from such a “bulk” analysis of
sequence-level selection to the true prize, which is inference on a per-sequence
level. Extracting the binding properties of a BCR or TCR from sequences, and
hence its potential for autoreactivity, is a grand challenge of computational bi-
ology that will not be solved soon. Perhaps the best strategy will be via protein
structural modeling, or via machine learning techniques applied to large data
sets of pre- and post-selection receptor sequences. Thus such per-sequence
analysis appears to be out of scope of the sort of probabilistic modeling consid-
ered here.
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T cell clonal expansion
T cells are stimulated to divide when they bind to an MHC loaded with a pep-
tide that they recognize. This is called clonal expansion.
As in the previous section, one can again consider two questions for clonal
expansion: first, what are bulk characteristics of the expanded repertoire, and
second, can we infer anything on individual TCR sequences? Regarding bulk
characteristics, abundance distributions of T cells have proven to be a fer-
tile means of learning about the patterns of antigenic stimulus and competi-
tion (81,82). Twin studies show a strong genetic effect of T cell clonal expansion
in terms of overall memory cell response and response against a specific immu-
nization (83). T cell development changes through age, which has been used to
show that our naive T cell repertoire is a complex mixture of cells generated at
different ages (61, 84). Aging clearly modifies both the existing repertoire and
our capacity to respond to novel stimulus (85).
Regarding individual sequences, it is interesting but difficult to associate
characteristics of specific TCR sequences with genetics and immune state. One
component of this is to develop relevant notions of similarity between recep-
tors, which can then be used to perform clustering and projection into a lower
dimensional space (86, 87). Using these and related tools, recent work has
moved towards a variety of machine learning goals, including clustering se-
quences according to their specificity using tetramer binding data (86,88), pre-
dicting new sequences that will bind a given epitope (88), identifying relation-
ships between TCR sequence and MHC use (80, 89), and finding sequences
or sequence characteristics that differ between groups (80, 90–92). Building
databases of epitope-TCR pairs (93) and high throughput measurement of affin-
ity (94) will certainly spur this development.☼ Probabilistic modeling can be used to estimate the chance of obtaining
a given TCR sequence, and thus has an important role in interpreting T cell
frequency data. Such models can be used to estimate the degree of antigen-
stimulated clonal expansion by comparing the probability of generation to the
TCR frequency (92). In addition, probabilistic modeling is appropriate for in-
terpreting bulk properties of repertoires in terms of clonal relationships within
the sequences. Here, we will certainly see continued development of models
describing the abundance distribution of T cell clones, and how these change
with age and immune stimulus.
On the other hand, predicting biophysical properties of individual TCR
sequences is not easily solved using a model-based probabilistic framework.
The binding fitness landscape of individual sequences is too “rough” for typ-
ical probabilistic methods— a small modification in the right place can take a
strongly binding receptor and make it non-binding.$ Thinking about a generative model that is too complex for inference, we
seem to fall between two stools: probabilistic generation models and models of
bulk properties seem tractable, whereas models of individual sequences seem
impossible or inappropriate with current probabilistic tools.
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B cell clonal expansion: antigenic stimulus
B cell clonal expansion is complex and delicious for statistical modeling, and
thus we will divide our description of this process among the following five
sections.
In response to immune challenge, dense accretions of lymphocytes form
structures known as germinal centers (95). These are the sites of B cell diversi-
fication, to which B cells gain entry by the ability to bind antigen. This diversi-
fication process includes mutation and selection processes that will be covered
in subsequent sections below. After responding to the original infection, mem-
ory B cells and plasma cells are exported from the germinal center; after export
these cells are mostly dormant until further stimulated. Serum antibody levels
are maintained by dynamically-controlled cell populations (96).
Methods are now emerging to predict antigen-antibody affinity from se-
quence data for specific antigens (97). One approach is to find shared se-
quence characteristics. For example, convergent sequence characteristics such
as gene usage, CDR3 length, and mutation load have been identified in re-
sponse to some vaccines (98). However, not all sequence characteristics will
have straightforward correlations: for example, an influenza vaccination ex-
periment with closely sampled time points did not see a correlation between
VJ gene usage and degree of expansion (99). Age is an important covariate of
this sort of analysis, as it changes the degree of hypermutation (100), how fre-
quently certain gene combinations are generated in the unselected repertoire,
and how gene combinations are selected in the memory repertoire (101).
Another approach is to build out databases of BCR sequences responsive
to specific antigens and look for similarity between them, in terms of both se-
quence similarity and time dynamics of re-activation (102–104). There is some,
though not plentiful, data with which to infer these patterns, and the most in-
formation is available for HIV antigens (105,106). This sort of approach may be
aided by improved modeling of the space of antigen-binding sequences, such
as with maximum-entropy models (107), or some other means of predicting
binding similarity using sequence information.
The effectiveness of a database-matching approach depends on similar BCR
sequences being used to bind a given antigen, which leads to the subject of
“public” repertoire analysis. This sort of analysis determines which sequences
are shared between individuals due to common antigen exposure and rela-
tively high-probability random sequence generation (108–110). To make sense
of the public repertoire one must understand the extent to which genetics and
negative selection determine the naive repertoire. For example, vaccination of
human twins gives rather different results (111), while there is significant ev-
idence of genetic predetermination for vaccination in mouse (112). Indeed, it
has recently been proposed that this represents a fundamental difference be-
tween the immune systems of these two species (113).
One can also consider various bulk properties of the memory BCR reper-
toire, and consider the difference between the naive repertoire and the ma-
ture repertoire. A deep sequencing study observed differences in gene us-
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age and CDR3 length (114). In addition, using appropriate lab and compu-
tational strategies, one can quantify and model the respective abundance dis-
tributions (114, 115).☼ Like TCR sequences, probabilistic models are needed in public repertoire
analysis of BCR sequences to disentangle the roles of similar rearrangements
and antigenic stimulus in generating similar or identical receptors. Analo-
gously, models of abundance distribution should inform us about the dynam-
ics of generation and selection, although there doesn’t appear to be much work
in this area yet. Representations of sequences such as maximum-entropy mod-
els may provide useful tools for characterizing groups of antibody sequences
binding a given antigen.
Although methods with more of a machine learning flavor may be a better
fit for inferences on individual sequences, it may be useful to combine prob-
abilistic models of sequence generation with probabilistic models of sequence
families binding a certain antigen.$ As for T cell receptors, we again fall between two stools.
B cell clonal expansion: somatic hypermutation
When B cells replicate, their BCR locus is mutated at a rate about a million
times higher than in normal replicating cells. This process is orchestrated by a
complex set of steps, starting with deamination of a cytosine to make a uracil,
and then proceeding down one of multiple paths of error-prone repair (116).
These steps lead to complex context dependence, determining which antibod-
ies are reachable via somatic hypermutation (117).
Several decades of work has focused on how these context “motifs” change
mutability, first by finding “hotspot” motifs that are especially mutable (21,118,
119) and then later by developing more quantitative approaches to describe the
influence of various sequence characteristics. This includes models estimat-
ing the mutability of all possible sub-sequences of some length (22, 120, 121)
or models that use sequence position and/or presence of individual bases at
specific distances to predict mutability (5, 122). Our group has recently gener-
alized these approaches into a penalized survival analysis framework that can
combine arbitrary sequence features, omitting those which do not clearly con-
tribute to improved model fit (24). An alternative way to formulate somatic
hypermutation is to consider substitution frequencies of the combined muta-
tion and selection processes on germline genes (6,123–125), although this does
not provide predictions for N-region nucleotides.
Accurate mutation rate estimation is important for interpretation and pre-
diction of B cell evolutionary patterns. This is clearly true for estimation of
natural selection (126–128), in which the mutation rate (the rate of introduction
of nucleotide changes) is compared to the substitution rate (the rate of such
changes that persist in the population) in order to estimate a natural selection
parameter. It is also important for understanding which antibodies are acces-
sible from a certain rearrangement (117); analysis of B cell evolution over long
timescales suggests decreasing mutability through time (129).
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Currently there is an unfortunate division between biologically-based mech-
anistic models and statistical models, which are so far only descriptive. Al-
though the pattern of mutations has been used to state qualitatively that cer-
tain factors are important in the SHM process (118, 130–133), this has not re-
sulted in rate estimates for the various repair pathways. The one exception is
a mathematical model of AID activity in terms of scanning and catalysis (134),
although other processes are essential to the somatic hypermutation process in
vivo (135). A more mechanistically-explicit model of DNA damage and local
error-prone repair should generate locally correlated sets of mutations more
effectively, a task at which current models fail (69).
In addition to the point mutations described above, somatic hypermutation
also introduces insertion-deletion mutations, or indels (136). The rate of indel
introduction is comparable to the rate of point mutation (137–139) although
most of these indels are filtered out by natural selection in the functional reper-
toire. Because the mechanisms for point and indel mutation are linked (116),
it is perhaps not surprising that correlation can be found between their loca-
tions (139). Although most indels are filtered out, some have important func-
tional consequences, such as in the development of broadly-neutralizing anti-
bodies to HIV (140).☼ Inference of point mutation models is just starting to use methods with a
probabilistic foundation, and more work needs to be done. One outstanding
challenge is that the process of somatic hypermutation happens on phyloge-
netic trees, and it is difficult to do model inference on phylogenetic trees with
context-sensitive models. Indeed, phylogenetic model inference typically inte-
grates out potential internal states as part of the model fitting process on the
tree; this is enabled by the use of the Felsenstein algorithm which requires an
independence-among-sites assumption (more details below). That assumption
is of course violated for context-sensitive models. Our group has used an ad-
ditional sampling step to marginalize out the possible ancestral sequences of
a given sequence, and avoid the need to do so in a fully phylogenetic context
by selecting only one sequence per clonal family (i.e. phylogenetic tree). Such
estimation has been previously done for simpler classes of models (141, 142).
We are not aware of any probabilistic models for indels specifically in the
somatic hypermutation process. For molecular sequences in general, such mod-
els first appeared in 1986 (143), followed by the foundational TKF models
(144,145). Recent work has defined a class of indel models with attractive com-
putational properties (146, 147).$ A more biologically explicit mutation model would consider AID deami-
nation and repair processes in terms of mismatch repair, base excision repair,
indel introduction and gene conversion (116). Although a fully specified mech-
anistic model would be challenging for efficient inference, it is certainly suit-
able for simulation. Our group is currently using our more flexible mutation
modeling setup (24) to “fish out” certain types of effects that will allow us to
estimate rates of these various pathways, and form the foundation for such
models.
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B cell clonal expansion: lineage development
B cells undergo a Darwinian process of mutation and selection in the germi-
nal center to improve binding to antigen. Each B cell entering the germinal
center founds a lineage (realized as a phylogenetic tree), and is the unmutated
ancestor of all of its mutated descendants. Mutation and selection happen in
the dark and light zones of germinal centers, respectively: in the dark zone
B cells reproduce, introducing additional diversity by the somatic hypermuta-
tion process described above, while in the light zone B cells compete to retrieve
antigen from follicular dendritic cells. Recent work has emphasized the impor-
tance of T cell help from retrieving antigen as opposed to direct stimulation to
reproduce from BCR crosslinking (31).
Affinity maturation is a dynamic population-level process. Using a mouse
engineered to express a reporter of apoptosis, researchers have found that
apoptosis is the “default” outcome in the absence of T cell help (148). Inten-
sive examination of individual germinal centers has led to the hypothesis of
“clonal bursts” in which B cells divide in rapid succession due to a strong T
cell stimulus (149). Despite what would seem to be a very strong selective
environment, phylogenetic analysis combined with affinity measurements has
not revealed a steady march towards increased affinity in sampled germinal
centers (149, 150). Existing antibodies and B cells, including those appearing
during the germinal center reaction (151) and those from prior exposures (152),
change the evolutionary dynamics of the germinal center reaction.
Germinal centers are not seeded by single naive cells. Indeed, random
florescence labeling shows that many cells initially seed germinal centers, al-
though these germinal centers often “resolve” to the descendants of a single
cell through competition (149). In addition, B cells entering the germinal cen-
ter need not be naive: mathematical simulation (153) and mutation analysis of
vaccination studies in mice (154) support the hypothesis that lineages can be
re-seeded from existing lineages.
So much previous work has been done analyzing B cell sequence lineage
development, that we will divide this section into further mini-sections.
Clonal family inference Many computational methods have been developed
to reconstruct the hidden aspects of B cell clonal expansion and infer the dy-
namics behind it. Any bulk sample of B cells mixes sequences deriving from
different naive cells and responding to different antigens. Thus, an impor-
tant first step for analysis is to group sequences into “clonal families,” namely,
collections of sequences that descended from a single naive cell. The most
popular means of doing this is to apply single-linkage clustering to the se-
quences, allowing sequences to cluster if they are annotated to have the same
V and J sequences, have the same CDR3 length, and are less than some fixed
Hamming distance apart. Needless to say, there are issues with each of these
assumptions. Somatic hypermutation may cause uncertainty as to germline
gene assignment, and insertion/deletion mutations (indels) may change CDR3
length. However, the assumption of a fixed cutoff, even a per-repertoire fixed
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cutoff (155), seems the most problematic. The most obvious counter-example to
this assumption is given by broadly-neutralizing antibodies against HIV, which
with around 100 mutations have the same order of divergence from germline
genes as these germline genes have to one another (156). From a phyloge-
netic perspective, fixed-cutoff methods make the surprising assumption that
branch lengths in the process of somatic hypermutation cannot be longer than
some fixed quantity. This assumption seems even less sensible when we con-
sider that repertoires are small samples from a large population; when we drop
leaves from a phylogenetic tree because of sampling, the resulting branches be-
come longer.
To avoid such assumptions, our group has developed a likelihood-based
means of inferring clonal families in our partis software package (7). We begin
by recasting the problem to one of inferring groups of sequences that have the
same naive sequence. This differs from the original question of inferring clonal
families, because the same naive sequence can be generated by two different
rearrangement events. To solve this question, ideally one would do a perfect
job of inferring a naive sequence from each mature sequence and then simply
cluster based on those inferred naive sequences. However, such a procedure
is not possible because there are many ways to obtain a given sequence from
different ancestors via somatic hypermutation. For this reason, the method
calculates a likelihood that two groups of sequences come from the same naive
ancestor, while integrating over possible naive sequences. By comparing this
likelihood to the alternative hypothesis that the two groups do not share ances-
try via a likelihood ratio, one is able to decide whether these two groups should
be merged into one. The method applies this likelihood-based framework via
agglomerative clustering in a manner reminiscent of the neighbor-joining al-
gorithm (157, 158). A naive implementation of this procedure would be far too
slow for actual use, and thus, the method uses many optimizations. Some of
these come without any drop in accuracy, whereas some strike a balance be-
tween computational tractability and accuracy.
Inferences of such clusters will always be an uncertain process, which in-
vites a Bayesian approach to obtain posterior distributions on the clusters. In-
deed, early unpublished versions of our procedure did this hierarchical ag-
glomeration via sequential Monte Carlo (SMC) (159), an algorithm that can
be thought of as a probabilistically-correct type of genetic algorithm. In SMC
one maintains a population of objects being inferred, and at each stage makes
some modification. In this case, our software maintained a population of dif-
ferent partial clusterings, and at each stage every partial clustering makes some
probabilistic merge weighted by a likelihood ratio.
This procedure was too slow and cumbersome to be applied to large se-
quence data sets. However, our group experimented with it enough to feel
confident that uncertainty was basically “one-dimensional,” such that the pri-
mary unknown quantity was the degree of clustering. Given that partis records
the sequence of clusterings that lead to each inferred cluster along with their
likelihoods, we left our Bayesian ambition there. A Bayesian clustering algo-
rithm based on a Dirichlet process mixture model has been described (160)
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although this algorithm does not appear to have been applied in practice.
Phylogenetic inference on B cell sequences Even once the clusters are fixed,
estimating the tree for each cluster is non-trivial. Besides the fact that estimat-
ing a phylogenetic tree is an inherently hard problem, B cell sequences have
features that differentiate them from typical applications of phylogenetics, and
thus require special algorithms. When sampling is dense, it is not unusual to
sample ancestor-descendant pairs. (Even if we aren’t actually sampling the
true ancestor of a given cell we may sequence a cell that is identical to it.) The
relatively short branch lengths between sequences has motivated an extensive
use of parsimony (161, 162), a method in which one chooses the tree that min-
imizes the number of mutations required to explain observed sequence data
at the tips. It is important to restrict the use of parsimony to cases with short
branch lengths as it is known to be statistically inconsistent when branches be-
come long (163); that is, it will produce the incorrect tree with probability one
in the limit of long sequences.
When single-cell sequencing is applied to a densely-sequenced sample, such
as one from a germinal center (149), each sequence comes equipped with a
meaningful abundance. This information can be productively used to guide
phylogenetic inference (164). The intuition behind this approach is that, first,
sampled abundance reflects the overall abundance of that genotype in the pop-
ulation, and second, more frequent cells are more likely to leave mutant de-
scendants. For this reason, we should prefer trees that connect descendants to
more frequently observed ancestors over those that do not.
Substantial information about the ancestral sequence can be inferred with
knowledge of germline sequences. Indeed, if one knows that a given V gene
was used in the process of VDJ recombination, we know the ancestral state for
that region of the sequence. This contrasts most applications of phylogenetics,
in which ancestral states are typically unknown. In order to integrate this infor-
mation one needs a computational framework that knows about both VDJ rear-
rangement and phylogenetics. Kepler has described such an approach, which
iteratively infers a tree while estimating a posterior on unmutated ancestor se-
quences (165). Each iteration takes the unmutated ancestral sequence with the
highest posterior probability, builds a tree using that sequence at the root, and
then re-estimates the posterior on the unmutated ancestor.
The highly context-sensitive mutation processes found in somatic hyper-
mutation (reviewed above) violate the near-universal phylogenetic assump-
tion of independent evolution between sites. This assumption is essential for
efficient likelihood computation in phylogenetics via the Felsenstein algorithm
(17). This can be understood intuitively as follows: if the substitution history at
the first site depends on the second, and the history at the second depends on
the third, then continuing this string of dependencies means that we must con-
sider evolution to be happening on the whole sequence at a time. This is com-
putationally intractable as the state space for nucleotides is four to the power
of the sequence length, defeating the traditional use of transition matrices.
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Thus if one wants to stay inside the usual likelihood-based framework for
phylogenetics one must use approximations to maintain the independence as-
sumption. An important step forward was recently made by incorporating
context information into a codon model (166). In codon models, one consid-
ers codons, rather than individual nucleotides, to be the units of evolution and
assumes independence between those codons. By averaging out the part of
nucleotide contexts that extend beyond the codon boundary, this work main-
tains a model that has independence between codons. This approach has the
additional advantage that one can estimate parameters of selection and context
sensitivity directly from the model.
B cell sequence analysis has more emphasis on phylogenetic ancestral se-
quence inference than is typical for other applications of phylogenetics, and
for good reason. Ancestral sequence inference methods enable a beautiful con-
vergence of computational analysis and laboratory experiments: estimated an-
cestral sequences can be expressed and built in the lab to test their proper-
ties (156,167,168). Such experiments, when combined with structural analysis,
give real insight into how substitutions lead to improved affinity. The compu-
tational tool for these analyses has typically been PHYLIP (169), although other
programs (170, 171) are faster or have additional features.
Selection inference We can get additional insight into the evolutionary pro-
cess by estimating the strength of natural selection on a collection of sequences
using codon-based methods. Such methods make inferences by considering
the relative rate of synonymous (between codons for an amino acid) to non-
synonymous (between amino acid) substitution. The intuition is that if there
is selection to preserve an amino acid, one will see an excess of synonymous
changes compared to nonsynonymous ones because nonsynonymous changes
will be selected out of the population. The opposite will hold for cases when
amino acid change is beneficial.
Such analysis is made difficult by the context-sensitive mutation process:
because the probability of substitution is influenced by the local sequence con-
text on one hand, and natural selection on codons on the other, false conclu-
sions can be drawn if one does not correct for it explicitly (126). Such correc-
tion is indeed possible (127, 128, 172–174). Repertoire-level selection has been
measured in the CDR region versus the framework region (127,172,173) and in
the “trunk” (edges leading from the naive ancestor to the most recent com-
mon ancestor of sampled sequences) versus the rest of the tree (174), with
results broadly consistent between individuals. This theme of consistency is
even more striking on a per-codon level (128), which shows diverse amounts
of selection at various sites in the framework region that are consistent among
individuals.
Tree shape and structure have also been used to estimate selective pressure
on ensembles of trees. Early work used graph-theoretic properties of trees to
estimate selection strength (175); correlation between these measures and selec-
tion strength was determined by simulation (29). Later authors found that such
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properties can be distorted by difficult-to-control experimental factors (176).
They proposed an alternative method mapping mutations onto the edges of
the tree and using patterns of replacement and silent nucleotide substitutions
filtered to only include substitutions on non-terminal branches (176).
A more ambitious goal is to estimate selection on a single tree at a time.
One recent approach compares tree balance (the number of descendants on one
side of a node versus another) at nodes directly below edges with amino acid
changes versus those without (177). An investigation of vaccine-responsive
trees (178) applied local branching rates (179) and a more classical investigation
of site-frequency spectra (180) to look for evidence of selective sweeps.
Modeling lineage development The dynamic evolution of antibodies in ger-
minal centers has been modeled for over a quarter century, for example leading
to an early prediction of re-entry of circulating B cells back into the germi-
nal center (30). An early computer simulation framework, “Clone,” although
not explicitly simulating an actual molecular sequence, simulated patterns of
mutation in various parts of the BCR and their consequences (181). Others
have performed ABC-like (see first section for an introduction to ABC) anal-
yses where they fit values such as mutation rate, selection, and clone affinity
based on concordance of summary statistics (27–29). These analyses have typ-
ically been independent of existing population genetics theory, although re-
cent work (178) makes use of site-frequency spectrum tools from population
genetics. Another vein of work uses agent-based and differential equation-
based modeling to iteratively improve compartmental models of B cell devel-
opment (182–191). For chronic infections such as HIV, antibody-pathogen co-
evolution certainly plays a role (192) although the dynamics between antibody
emergence and viral escape are difficult to pin down (193). Some researchers
have found a “trunk-canopy” tree structure from mature sequence data, in
which a long “trunk” branch from the root extends from the naive sequence,
after which there is a “canopy” of diversification (174). However, it has been
pointed out that the extent to which this structure is seen depends on the level
of clustering (194).☼ The previous review shows the disjointed state of the field: although clonal
clustering, phylogenetics, selection inference, and modeling are all describing
aspects of the same underlying process, they are divided into different prob-
lems (note that rearrangement inference, which is closely tied in with phyloge-
netic estimation, was relegated to its own section above, while isotype, which
is closely tied with mutation processes on trees, appears in the next section!).
We must work towards unifying these various aspects in a shared framework.
Bayesian statistics offers a coherent framework for such information shar-
ing and integration over uncertain latent states. Although estimation of these
complex posteriors will not be easy, we will be rewarded by more accurate
inferences, leading to a more complete understanding of how affinity matura-
tion works. Our group is currently building on prior work (165) to develop
a Bayesian sampling procedure on trees that integrates out uncertainty in the
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unmutated common ancestor using a hidden Markov model.
We are also inspired by the work of Jonathan Laserson and colleagues (160,
195) who describes how sampling ancestral sequences explicitly as part of an
MCMC can actually increase efficiency. This echoes earlier work in a more gen-
eral setting (196). The value of such sampling will be even greater when using
more complex context-sensitive models, for which calculating likelihoods cur-
rently requires more intensive extensions to Gibbs sampling procedures (e.g.,
that of Chib (197)) to compute the marginal likelihood. Other types of analysis,
such as that of selection pressure (128), also require ancestral sequence infer-
ence. Thus we believe that the next generation of phylogenetic algorithms for
BCR sequences will infer a joint posterior on ancestral sequences and trees.
We also believe that tree-valued stochastic models will provide a unified
foundation for learning about the diversification process from B cell sequence
data. Researchers working on viral populations have developed sophisticated
tools for learning about viral spread by estimating ancestral population size
using Bayesian “skyline” analysis (198) and phylogenetic generalized linear
models (15). Somewhat analogous stochastic models for B cell development
have been devised, but have only been used to generate distributions of sum-
mary statistics rather than being used for inference (28). A more powerful tactic
will be to develop models with parameters of interest and perform parameter
inference directly.
Although repertoire-scale inference with a “dream” algorithm getting pos-
terior distributions of all relevant parameters will not be possible, we can scale
our computational ambition to the question at hand. If we are very interested
in a specific clonal family, it may be worth expending considerable computa-
tional effort in order to get high quality inferences for that family. This may
include probabilistically sampling alternative clusterings of that clonal family.
On the other hand, if we are looking for repertoire-level characteristics we will
want to scale back our effort on each individual family in order to get an overall
picture (although it is important that such algorithms are unbiased).$ Realistic forward-time models are essential to help guide the design and
implementation of inferential algorithms. For example, there is currently a
need for models of affinity maturation that generate nucleotide sequences and
trees interdependently with some level of realism. Although antibody affinity
models are relatively old (199) and plentiful (see above), we aren’t aware of any
that generate nucleotide sequences. Our group is currently developing such a
model as part of a benchmarking exercise of ancestral reconstruction methods.
B cell clonal expansion: isotype
Antibodies have an isotype-determining constant region that establishes the
function of the antibody in the immune system. Isotype can change through
class-switch recombination, which arises due to double-stranded breaks result-
ing from AID deamination (116, 200). High-throughput sequencing including
isotype information is now available, and is shining light on this process. For
example, there are significant differences between isotypes in terms of their
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levels of somatic hypermutation (201). This new data is also elucidating the
rate with which antibodies switch isotype classes (202,203). An analysis of sis-
ter lineages on either side of a branch point has suggested that the probability
of switching to the various other isotypes is determined by more than just the
current isotype (202): rather, there is some additional hidden factor that deter-
mines the switching probability. This could be summarized by saying that the
isotype-switching process does not satisfy the Markov property.☼ If we do assume the Markov property, one can formulate an isotype model
using existing continuous-time trait models. Inference under such models is
well developed from both maximum-likelihood (204) and Bayesian (205) per-
spectives. Adding isotype as a hidden state in phylogenetic inference would
be straightforward.$ One may also wish to model a non-Markov latent state for which existing
inferential techniques will not apply. Another interesting type of model would
be one in which mutation and isotype-switching are linked probabilistically.
Estimating the complete adaptive immune response
Although repertoire sequencing offers a remarkable perspective into the com-
plex process of immune state, it will always offer an incomplete picture of the
immune response. First, it is well-acknowledged that we are taking a small
sample from a very large population. As such, it is common to extrapolate the
total number of unique immune receptors from a sample (206).
However, this is not the whole story: the common practice of sequencing
from blood may not reflect what is happening with B and T cells in other com-
partments. Recent work is beginning to lay the foundation for understanding
the whole B and T cell response from blood samples. This has included a “B cell
atlas” of samples from many tissues of organ donors (207), as well as sequen-
tial fine needle aspirates from rhesus (208), and sequencing from individual
germinal centers using lymph node dissection in mice (149).
In another direction one would like to understand the essential role that cir-
culating antibodies play in the immune response. Although B cell sequencing
gives some idea of what antibodies can be made, it is certainly not the same as
assaying the antibodies present in an individual. The soluble antibody reper-
toire is determined by expression and antibody lifetime. To do this, recent work
has combined protein mass spectrometry with antibody sequencing (209, 210).
Hopefully new protein sequencing methods (211) will expand our perspective
on soluble antibodies.
One may continue along these lines and say that even the pool of circu-
lating antibodies are not the most interesting factor, and rather one should be
interested in the collection of antigens that can be bound by those antibodies.
For this, recent work has used antigen microarrays (212,213) to infer what pep-
tides can be bound by circulating antibodies. For T cells, yeast display has
been used to identify the peptide specificity of TCRs found in cancer (214). Ab-
stracting one notch further, one can use immunological assays between viral
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strains to assay an antigenic “distance” between them (215, 216) that captures
cross-reactivity of antibodies.
These complexities are well known to theoreticians. The doctrine of “orig-
inal antigenic sin” is over 60 years old (217) and modern methods continue to
support past exposures as being essential for future development (152,218,219).
Perhaps the closest analysis of actual sequences are models of population-level
immunity in which the fitness of a given influenza sequence is in part deter-
mined by its similarity to existing sequences to which the population is al-
ready presumably immune (220, 221). There are also controlled experiments
and mathematical models working to understand the impact of antibody feed-
back (151, 188, 189, 222, 223), although this work hasn’t been generalized to an
inferential framework that can be used to understand individual repertoire
data sets. “Mutational antigenic profiling” (224–226), which reveals how mu-
tating an antigen can change antibody binding, and “deep mutational scan-
ning”, used to understand the impact of antibody sequence variation on bind-
ing (227, 228), may be helpful in these efforts.☼ Given a lot of “B cell atlas” type data, one might be able to develop a
migration model between the various compartments and infer rates based on
observations of the same or related clones in different compartments. The chal-
lenge with such a project will be to untangle re-seeding from early seeding and
partial persistence. Also, using such data, one may be able to model cell pop-
ulation sizes of difficult-to-sample compartments from ones that are easier to
sample.$ One could dream of a model that attempts to capture the antigenic space
that is covered by existing circulating antibodies. In particular, recent efforts
introduce antibody landscapes in the context of influenza (229).
Conclusion
We have reviewed opportunities for probabilistic modeling in B and T cell se-
quence analysis. To summarize, probabilistic models have a lot to contribute
to rearrangement and lineage inference. However, inferences on the functional
properties of individual sequences (such as for initial selective filters or antigen
binding) seem better done with machine learning methods rather than genera-
tive models for which likelihood calculation is not tractable. For those aspects
well suited to probabilistic modeling, we will be rewarded for integrating var-
ious aspects into a single framework where one level can communicate impor-
tant information, including uncertainty, to another level. For example, from B
cell sequence analysis
• There is considerable signal in patterns of shared mutation that can help
guide clustering inference, and the correct way of doing so is to combine
phylogenetic inference with clustering.
• It is common to include an inferred, unmutated common ancestor into a
sequence alignment for phylogenetic inference. Accounting for the cor-
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responding uncertainty is important to gain accurate inferences on the
processes that led to the observed sequences.
• Phylogenetic trees are also uncertain, and disregarding that uncertainty
will skew our downstream analyses of selection and models.
This model hierarchy can extend beyond the single-sample level to individual-
level analysis through time, or population-level analysis. The parameters we
learn from these larger studies, such as germline gene existence and frequency,
can feed back down to improve per-sample analysis. They can also be used to
analyze predictors of individual-level immune variation (230).
The computational statistician interested in immune receptor modeling is
blessed with a complex biological system to analyze, intractable computational
problems heaped on top of one another, and an ever-expanding collection of
data sets generated from various in-vivo and in-vitro perturbations. New meth-
ods are needed to perform inference under complex hierarchical models of im-
mune receptor development for the optimistic program laid out in this paper
to become a reality. Although the field of computational immunology dates
back many decades, we can gain inspiration and adapt techniques from the
even longer tradition of macroevolutionary and ecological theory. There, we
have seen a complex interplay of generative models, summary statistics, and
inferential models that have enabled the field’s progress.
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